3 companies unite to develop POC coronavirus serology test

LabPulse.com staff writers
Apr 16, 2020
2020 03 25 23 27 0591 Hands Shaking Deal 400

True Diagnostics, Infectolab, and Veravas have teamed up to develop and market a point-of-care (POC) rapid serology test for the novel coronavirus.

The VeraTest SARS-CoV-2 immunoglobulin A/immunoglobulin G (IgA/IgG) rapid test will determine whether antibodies against COVID-19 have been detected in a blood sample, with results available in fewer than 15 minutes, according to the companies.

The team effort combines the following:

  • True Diagnostics' TrueDx platform for POC diagnostics
  • Infectolab's COVID-19 serology testing services and infectious disease expertise
  • Veravas' VeraPrep clean and capture technologies

The test is designed to bind and detect antibodies specific to SARS-CoV-2 and remove cross-reacting antibodies to other types of coronaviruses, the companies said.

Latest in COVID-19
Needle Syringe2 Social
International consortium launches project to develop next generation of vaccines
March 15, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Gavel Scale Justice Social
COVID-19 fraud conviction overturned by federal judge
January 9, 2024
Handcuffs Gavel Social
CEO of Decision Diagnostics pleads guilty in COVID-19 test fraud scheme
December 11, 2023
Related Stories
2020 04 29 20 30 6458 Medical Worker Blood Test 400
PCR
Rapid point-of-care COVID-19 test shows promise in clinical study
2017 01 30 15 46 05 570 Cdc Logo 400
COVID-19
CDC details new serology test for COVID-19
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400
510(k)
NovaBay inks COVID-19 antibody test distribution deal
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in COVID-19
International consortium launches project to develop next generation of vaccines
By Matt Limb
An international consortium of researchers specializing in human challenge studies is embarking on a $57 million project to develop advanced virus-blocking coronavirus vaccines.
March 15, 2024
Needle Syringe2 Social
CorDx submits EUA application for COVID-19/influenza rapid test
By LabPulse.com staff writers
CorDx has submitted an Emergency Use Authorization (EUA) application for its CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test to the U.S. Food and Drug Administration (FDA).
February 10, 2024
Influenza Virus Social
COVID-19 fraud conviction overturned by federal judge
By LabPulse.com staff writers
A federal judge has overturned a jury verdict convicting a Maryland doctor of five counts of COVID-19 testing fraud.
January 9, 2024
Gavel Scale Justice Social
CEO of Decision Diagnostics pleads guilty in COVID-19 test fraud scheme
By LabPulse.com staff writers
The CEO and sole director of Decision Diagnostics has pleaded guilty to securities fraud, wire fraud, and obstruction of an official proceeding in connection with false claims of the firm developing a rapid COVID-19 test early in the pandemic.
December 11, 2023
Handcuffs Gavel Social
Texas lab owner pleads guilty in $1.7M Medicare fraud
By LabPulse.com staff writers
A Plano, TX, lab owner has pleaded guilty to orchestrating a scheme to obtain $1.7 million from Medicare fraudulently, announced the office of the U.S. Attorney for the Northern District of Texas in a statement.
December 6, 2023
Handcuffs Gavel Social
AI model shows promise detecting COVID-19 in low-resource settings
By Will Morton
An artificial intelligence (AI) model shows promise for diagnosing COVID-19 in low-resource settings with severe shortages of medical experts, including in many African regions, according to a study published November 11 in Scientific Reports.
November 14, 2023
Artificial Intelligence Ai Hand Social
3EO Health to launch FDA-approved COVID-19 test
By Matt Limb
Molecular diagnostics startup 3EO Health is preparing to launch a newly approved SARS-CoV-2 test with its portable molecular device, saying it will “expand access” to the technology.
October 20, 2023
Coronavirus Hologram Blue Social
Researchers develop technique for onsite detection of SARS-CoV-2
By LabPulse.com staff writers
Researchers have developed a portable laboratory device for rapid onsite detection of SARS-CoV-2 RNA which holds promise for scenarios in which there is no or limited access to testing laboratories.
October 10, 2023
Coronavirus Covid Blue Social
FDA issues EUAs for 2 POC COVID-19 tests
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for two separate point-of-care (POC) assays for SARS-CoV-2 developed by Tangen Biosciences and SD Biosensor.
October 4, 2023
3d Closeup Coronavirus Social
Study launched on early intervention with immune modulators in COVID-19
By LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
By LabPulse.com staff writers
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
By Nick Paul Taylor
A lack of standardization of infectious disease consumables was “a huge, unanticipated issue during the pandemic” that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
Doctor Nurse Mask Icu Social
Page 1 of 34
Next Page